Delve into the promising use of mebendazole, a well-established antiparasitic, as a repurposed agent in oncology. Led by Dr. Nathan Goodyear, this course explores mebendazole’s anticancer mechanisms—such as microtubule disruption, apoptosis induction, and antiangiogenic effects. You’ll learn about its pharmacokinetics, dosing strategies, synergy with conventional therapies, and safety considerations. Designed for integrative practitioners, this module offers evidence-based insight into how mebendazole may target multiple cancer hallmarks and support metabolic approaches to care.